Alabama Rot May 2017 Reading Conference

The Cutaneous and renal glomerular vasculopathy focus meeting group, aka the Alabama Rot Conference, was held in the Trophy Room at the Madejski Stadium in Reading on Tuesday, May 10th 2017.

Chris Street from attended the conference.

The agenda included an update on the current situation, ongoing and future research, sample collection and storage, data capture and fundraising.

Speakers included David Kavanagh, Professor of Complement Therapeutics, Newcastle University. He spoke about ‘Haemolytic Uraemic Syndrome – experience from the National Renal Complement Therapeutic Centre.’

Dr Tristan Cogan, Senior Lecturer in Infectious Disease at the University of Bristol spoke about ‘Spatial distribution of bacteria in tissues of CRGV cases’.

Amanda Boag, clinical director of Vets Now attended the conference:

“attendees put their heads together to consider an action plan for the disease. A huge amount of research is also being carried out into its causes. Scientists are looking for infectious agents such as bacteria, viruses and fungi as well as toxins in dogs affected. At the moment there is no vaccine for Alabama rot as the cause has not been established. Once this is the case it’s hoped a vaccine could be developed.” Vets-Now

David Walker of Anderson Moores, who organised the conference, said:

“The conference was very positive, with everyone contributing greatly to the discussion, and we look forward to continuing to work with our fellow professionals to research this condition. We’ve already started the process of setting up a steering committee, to help focus the enormous experience and knowledge from the 30 specialists who gave up their time for free to attend. Among the items we discussed was the sharing of data from similar human health issues to identify any possible connections.” Express

David Walker continued:

“Early evidence had suggested a possible environmental link to dogs being walked in muddy woodland areas, but human and veterinary experts are now looking for clues at a cellular level. Evidence does, however, suggest a seasonal factor may be at play. Mr Walker said 90% of confirmed CRGV cases occurred between the colder months of November to May, with February and March being the peak UK CRGV months. The key to cracking the mystery of CRGV was a collaboration between the human medicine and veterinary medicine disciplines, and that is why the focus group had been created. Collaboration is key. Setting up links with universities across the UK and links with specialists from the human fields will really help push things forward.  There’s been a huge amount of work done in separate little projects to this point, but now it’s more about a targeted approach.” Veterinary Times

Vet Record

Veterinary Record (behind paywall) Vol 180, Issue 20